TrialHepatology communications2026

Cholestasis-reducing effects of bezafibrate on survivors of biliary atresia with native livers: A prospective phase II trial.

Yunosuke Kawaguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.